Piper Jaffray analyst Matt O\'Brien initiates coverage on Ra Medical Systems Inc. (NYSE: RMED) with a Overweight rating and a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE